Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequelae of Ebola virus disease: the emergency within the emergency.
Vetter P, Kaiser L, Schibler M, Ciglenecki I, Bausch DG. Vetter P, et al. Among authors: ciglenecki i. Lancet Infect Dis. 2016 Jun;16(6):e82-e91. doi: 10.1016/S1473-3099(16)00077-3. Epub 2016 Mar 22. Lancet Infect Dis. 2016. PMID: 27020309 Review.
Epidemiological characteristics and real-world treatment outcomes of hepatitis C among HIV/HCV co-infected patients in Myanmar: A prospective cohort study.
Swe TM, Johnson DC, Mar HT, Thit P, Homan T, Chu CM, Mon PE, Thwe TT, Soe KP, Ei WLSS, Tun NL, Lwin KZ, Karakozian H, Aung KS, Nguyen A, Ciglenecki I, Tamayo N, Loarec A. Swe TM, et al. Among authors: ciglenecki i. Health Sci Rep. 2023 Feb 17;6(2):e1119. doi: 10.1002/hsr2.1119. eCollection 2023 Feb. Health Sci Rep. 2023. PMID: 36819986 Free PMC article.
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus Disease.
Gignoux E, Azman AS, de Smet M, Azuma P, Massaquoi M, Job D, Tiffany A, Petrucci R, Sterk E, Potet J, Suzuki M, Kurth A, Cannas A, Bocquin A, Strecker T, Logue C, Pottage T, Yue C, Cabrol JC, Serafini M, Ciglenecki I. Gignoux E, et al. Among authors: ciglenecki i. N Engl J Med. 2016 Jan 7;374(1):23-32. doi: 10.1056/NEJMoa1504605. N Engl J Med. 2016. PMID: 26735991 Free article.
Ebola Virus Disease Complications as Experienced by Survivors in Sierra Leone.
Tiffany A, Vetter P, Mattia J, Dayer JA, Bartsch M, Kasztura M, Sterk E, Tijerino AM, Kaiser L, Ciglenecki I. Tiffany A, et al. Among authors: ciglenecki i. Clin Infect Dis. 2016 Jun 1;62(11):1360-1366. doi: 10.1093/cid/ciw158. Epub 2016 Mar 21. Clin Infect Dis. 2016. PMID: 27001797 Free PMC article.
Experimental Treatment of Ebola Virus Disease with Brincidofovir.
Dunning J, Kennedy SB, Antierens A, Whitehead J, Ciglenecki I, Carson G, Kanapathipillai R, Castle L, Howell-Jones R, Pardinaz-Solis R, Grove J, Scott J, Lang T, Olliaro P, Horby PW; RAPIDE-BCV trial team. Dunning J, et al. Among authors: ciglenecki i. PLoS One. 2016 Sep 9;11(9):e0162199. doi: 10.1371/journal.pone.0162199. eCollection 2016. PLoS One. 2016. PMID: 27611077 Free PMC article. Clinical Trial.
The impact of control strategies and behavioural changes on the elimination of Ebola from Lofa County, Liberia.
Funk S, Ciglenecki I, Tiffany A, Gignoux E, Camacho A, Eggo RM, Kucharski AJ, Edmunds WJ, Bolongei J, Azuma P, Clement P, Alpha TS, Sterk E, Telfer B, Engel G, Parker LA, Suzuki M, Heijenberg N, Reeder B. Funk S, et al. Among authors: ciglenecki i. Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721):20160302. doi: 10.1098/rstb.2016.0302. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28396473 Free PMC article.
Vaccination against cholera in Juba - Authors' reply.
Ciglenecki I, Azman AS, Rumunu J, Cabrol JC, Luquero FJ. Ciglenecki I, et al. Lancet Infect Dis. 2017 May;17(5):480-481. doi: 10.1016/S1473-3099(17)30184-6. Lancet Infect Dis. 2017. PMID: 28447952 No abstract available.
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ; PALM Writing Group; Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallée D, Nordwall J; PALM Consortium Study Team. Mulangu S, et al. N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27. N Engl J Med. 2019. PMID: 31774950 Free PMC article. Clinical Trial.
A meta-analysis of clinical studies conducted during the West Africa Ebola virus disease outbreak confirms the need for randomized control groups.
Dodd LE, Follmann D, Proschan M, Wang J, Malvy D, van Griensven J, Ciglenecki I, Horby PW, Ansumana R, Jiang JF, Davey RT, Lane HC, Gouel-Cheron A. Dodd LE, et al. Among authors: ciglenecki i. Sci Transl Med. 2019 Nov 27;11(520):eaaw1049. doi: 10.1126/scitranslmed.aaw1049. Sci Transl Med. 2019. PMID: 31776287
The first reactive vaccination campaign against hepatitis E.
Ciglenecki I, Rumunu J, Wamala JF, Nkemenang P, Duncker J, Nesbitt R, Gignoux E, Newport T, Heile M, Jamet C, Rull M, Azman AS. Ciglenecki I, et al. Lancet Infect Dis. 2022 Aug;22(8):1110-1111. doi: 10.1016/S1473-3099(22)00421-2. Lancet Infect Dis. 2022. PMID: 35870452 No abstract available.
117 results